Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): John M Miller , Anil V Yadav Added: 3 years ago
In the nearly 30 years since Wellens et al. categorized most of the currently used electrocardiographic (ECG) criteria for distinguishing supraventricular tachycardia (SVT) with aberrant interventricular conduction from ventricular tachycardia (VT),1 there have been relatively infrequent and largely incremental enhancements to the art and science of making this distinction. In most published… View more
Author(s): Joo-Yong Hahn Added: 1 year ago
ACC.23/WCC - Principal investigator, Dr Joo-Yong Hahn (Samsung Medical Center, KR) joins us to discuss the findings of the RENOVATE-COMPLEX-PCI late-breaking trial (Samsung Medical Center). The investigators compared clinical outcomes between intravascular imaging guided (IVUS) versus angiography guided (OCT) percutaneous coronary intervention (PCI) in 1639 patients with complex lesions … View more
The goal of the CICT Conferences is to promote high quality, patient-centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. The uniqueness of the CICT conferences lies in the open forum transparent discussion of controversial topics allowing free flowing interaction between audience and faculty. The content of these meetings addresses a wide range… View more
Author(s): Bill D Gogas , Duk-Woo Park Added: 2 years ago
In this video, USC Editor-in Chief Dr Bill Gogas discusses the upcoming 2021 Complex PCI event with Dr Duk-Woo Park (Asan Medical Center, Seoul, KR). Dr Park provides an overview of what we can expect to see at Complex PCI this year. View more
Author(s): Mirvat Alasnag , Valeria Paradies , Nicola Ryan , et al Added: 4 months ago
Author(s): Srinivas Murali Added: 3 years ago
Introduction Pulmonary arterial hypertension (PAH) is a disease affecting the pulmonary vascular endothelium of the small pulmonary vessels that causes progressive elevations in pulmonary vascular resistance, leading to right ventricular failure and death. PAH can result from a number of causes or associated risk factors. A clinical classification (Evian classification) was developed in 1993 and… View more
Author(s): Srinivas Murali Added: 3 years ago
Pulmonary arterial hypertension (PAH) is a disease affecting the pulmonary vascular endothelium of the small pulmonary vessels that causes progressive elevations in pulmonary vascular resistance, leading to right ventricular failure and death. PAH can result from a number of causes or associated risk factors. A clinical classification (Evian classification) was developed in 1993 and subsequently… View more
Author(s): Brandon Quintana , Akram Ibrahim Added: 3 years ago
Percutaneous coronary intervention (PCI) has been rapidly evolving since its initial application in 1977. Over the years, it has become a mainstay of the treatment of coronary artery disease, including acute coronary syndromes and stable ischemic heart disease. With the advent of novel ancillary technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), it has… View more